|
|
|
GTCbio, Boston,MA
March 9-10 , 2009
The 5th annual Stem Cell Research & Therapeutics Conference provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells. As alternative sources of human embryonic stem cells emerge, new and exciting federal funding opportunities are arising.
The conference will review recent developments in policies regarding funding for Stem Cell Research. Private funding from the Pharmaceutical Industry will also be addressed. These and other questions will be the highlight of GTCbio`s 2009 Stem Cell Research and Therapeutics conference. Sessions for the conference include: • Differentiation of Stem Cells • Induced Pluripotent Cells, Reprogramming & Epigenomics • Regenerative Medicine & Tissue Engineering • Stem Cell In vivo and Molecular Imaging • Regulatory Aspects, Commercialization & Funding Opportunities • Cancer Stem Cells • Stem Cell Applications in Drug Discovery • Pre-Clinical & Clinical Trials of Stem Cell Therapy • Technology in Stem Cell Research
This event provides a unique venue for attendees to network and meet with leading experts in the most comfortable and informal of settings.
|
|
|
|
|
|
Organized by:
|
|
GTCbio |
|
Invited Speakers:
|
|
| DISTINGUISHED SPEAKERS & ADVISORS:
Kazuhiro Aiba Senior Scientist SCDI
Anne Bang Associate Director, Stem Cell Technologies Novocell, Inc.
Miriam Bibel Senior Research Investigator / Project Team Head, Neurodegeneration Novartis
Petter Bjorquist Ph.D., Senior Principal Scientist, Project Manager Cellartis AB
Gregory A. Bonfiglio Managing Partner Proteus Venture Partners
Yen Choo, Ph.D. CEO Plasticell Limited
Aaron T. Chuang Manager Cellular Neurobiology GlaxoSmithKline
Jay Edelberg Group Director - Clinical Biomarkers, Discovery Medicine & Clinical Pharmacology DMCP Bristol-Myers Squibb Co.
Kurt C Gunter, M.D. Global Medical Director, Regenerative Medicine Hospira, Inc.
Robert M. Hoffman, Ph.D. President AntiCancer, Inc. Professor of Surgery University of California, San Diego
Johnny Huard University of Pittsburgh Stem Cell Research Center
Edward Lanphier President & Chief Executive Officer Sangamo BioSciences
Tracey Lodie Associate Director Genzyme
Bradley J. Martin, Ph.D. Director - Product Development Aastrom
David Schaffer Professor, Chemical Engineering, Bioengineering & The Helen Wills Neuroscience Institute UC Berkeley
Geoff Symonds Senior Research Director & Global Product Leader, HIV Gene Therapy Johnson & Johnson Research
Anthony Ting, Ph.D. Director, Regenerative Medicine Athersys, Inc.
Chunhui Xu Group Leader Geron
Philip Wright Chief Executive Stem Cells for Safer Medicines Ltd.
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
February 10th 2009
|
|
|
|
|
|
Registration:
|
|
https://gtcbio.com/userpart/user_registration.aspx
|
|
E-mail:
|
|
raniah@gtcbio.com
|
|
|
|
|
|
|
|